Market Research Logo

Turkey Pharmaceuticals & Healthcare Q4 2018

Turkey Pharmaceuticals & Healthcare Q4 2018

Key View:

Turkey's pharmaceuticals and healthcare markets are set for robust growth over the long term, outperforming themajority of its regional peers. Continued growth in public spending will support market growth, driven by the Health TransformationPlan. However, we highlight that increasing macro risks, emphasised by the lira sell-off in August 2018, will increasingly placedownside risks to this expansionary fiscal outlook, leading to growth deceleration over the long term. Moreover, innovativedrugmakers will remain averse to the high degree of risks inherent in the market from localisation and pricing policies.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Abdi Ibrahim
EastPharma (Deva)
Eczacibaşi Healthcare
Mustafa Nevzat IIac Sanayi (MN) Pharmaceuticals
Sanovel Pharmaceutical
Turkey Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report